StonvexLoading…
StonvexStonvexStonvexCore line items from AMZN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $716.92B | $637.96B | $574.78B | $513.98B |
Operating Income | $79.97B | $68.59B | $36.85B | $12.25B |
Net Income | $77.67B | $59.25B | $30.43B | $-2.72B |
EPS (Diluted) | $7.17 | $5.53 | $2.90 | $-0.27 |
Total Assets | $818.04B | $624.89B | $527.85B | $462.68B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $86.81B | $78.78B | $73.39B | $53.89B |
Free Cash Flow OCF − CapEx | $7.70B | $32.88B | $32.22B | $-16.89B |
Shares Outstanding | 10.73B | 10.59B | 10.38B | 10.24B |